Nature's Miracle Holding Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Nature's Miracle Holding Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $9.26M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $8.93M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $18.62M | Apr 16, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.59M | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $300.1K | Apr 16, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($451.0K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.81M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($948.9K) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $1.67M | Apr 16, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.99M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($13.65M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($7.34M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($2.46M) | Apr 16, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.15M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($10.35M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($6.04M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($1.77M) | Apr 16, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.88M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $7.13M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $3.16M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $3.44M | Apr 16, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.99M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($5.93M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($1.68M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($2.45M) | Apr 16, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $52.9K | Apr 16, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.41M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $11.31M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $14.20M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $20.85M | Apr 16, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.69M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $25.65M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $20.92M | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $20.23M | Apr 16, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($12.74M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($14.34M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | ($6.72M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $617.4K | Apr 16, 2025 |
| FY2023 | Dec 31, 2021 | $1.77M | Apr 16, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $1.02M | Apr 16, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($36.80M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($24.73M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($8.25M) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | ($909.7K) | Apr 16, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.7K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $420.1K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $221.8K | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $810.4K | Apr 16, 2024 |
| FY2024 | Aug 18, 2022 | $45.5K | Apr 16, 2025 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $80.2K | Apr 16, 2025 |
| FY2024 | Dec 31, 2023 | $114.6K | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | $147.4K | Apr 16, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (11) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (9) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (11) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (9) | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 112.85M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 2.45M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 742,416 | Apr 16, 2025 |
| FY2023 | Dec 31, 2022 | 22.27M | Apr 16, 2024 |